Extra Layer Of Support
NCT03532997 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151
Last updated 2020-02-26
Summary
The investigators aim to introduce patients with advanced cancer to supportive care resources, including specialty palliative care, through a novel app called "ELOS" (stands for "extra layer of support) in a prospective cohort study. The investigators will compare participant acceptance of this new electronic tool to industry standards and follow ultimate referrals to outpatient palliative care compared to historical, matched controls.
Conditions
- Advanced Cancer
- Palliative Care
Interventions
- OTHER
-
ELOS
The investigators aim to introduce patients with advanced cancer to supportive care resources, including specialty palliative care, through a novel web-based application called "ELOS" (stands for "extra layer of support) in a prospective cohort study.
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
collaborator OTHER - lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-01
- Primary Completion
- 2020-01-07
- Completion
- 2020-01-07
Countries
- United States
Study Locations
More Related Trials
-
Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00004171 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas
NCT01329900 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00004908 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery
NCT00006126 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
NCT06782555 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00005613 ·Status: COMPLETED ·Phase: PHASE2
-
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
NCT00002948 ·Status: TERMINATED ·Phase: PHASE1
-
High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia
NCT00002788 ·Status: COMPLETED ·Phase: PHASE1
-
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis
NCT00007995 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma
NCT00005824 ·Status: COMPLETED ·Phase: PHASE2
-
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
NCT06724237 ·Status: RECRUITING ·Phase: PHASE3
-
Emergency Medicine Palliative Care Access
NCT03325985 ·Status: COMPLETED ·Phase: NA
-
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
NCT02249949 ·Status: COMPLETED ·Phase: PHASE2
-
G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
NCT00554463 ·Status: COMPLETED ·Phase: PHASE2
-
Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma
NCT01740557 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
NCT02472392 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma
NCT00470223 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed or Refractory Hodgkin's Lymphoma
NCT00255723 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
NCT00002838 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
NCT00020566 ·Status: UNKNOWN ·Phase: PHASE3
-
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
NCT00539500 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Single Patient Protocol: A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
NCT04135092 ·Status: NO_LONGER_AVAILABLE
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004903 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00003957 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer
NCT00004135 ·Status: COMPLETED ·Phase: PHASE2